These are not FDA approved yet - this trial + VISIONARY for Sibeprenlimab will lead to approval soon

Approved =
Nefecon
Atrasentan
Sparsentan
Iptacopan

(I think)
#Nephjc

Off label use tried in small studies, awaiting Double PROTECT study

Noted

Everything said and done - although eGFR diff may signal ominous outcomes - practically speaking following one eGFR over time and seeing the eGFR fall predicts outcomes better than anything else ! And that’s what would be feasible across economies ! #NephJC

Missed the #NephJC yesterday, but increasingly using Ritux for SDNS and even redosing at 6mo-1yr. Some stay in remission longer with add MmF

I do the same with any agent. Treat for 2 years then try off. If relapse, then another 2 years. #NephJc I don’t think there’s great data. Just seems a good balance of risk.

No, as someone who has used it before and now no longer using #NephJC

Short window to work with!
#NephJC

Due to cost and other logistics we stopped PFA, haven’t used desmo preemptively
#NePhJC